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Brief report
Severe hereditary spherocytosis and distal renal tubular acidosis associated
with the total absence of band 3
Maria Letı´cia Ribeiro, Nicole Alloisio, Helena Almeida, Clara Gomes, Pascale Texier, Carlos Lemos, Gabriela Mimoso, Laurette Morle´,
Faı¨za Bey-Cabet, Rene´-Charles Rudigoz, Jean Delaunay, and Gabriel Tamagnini
Absence of band 3, associated with the
mutation Coimbra (V488M) in the homozy-
gous state, caused severe hereditary
spherocytosis in a young child. Although
prenatal testing was made available to
the parents, it was declined. Because the
fetus stopped moving near term, an emer-
gency cesarean section was performed
and a severely anemic, hydropic female
baby was delivered. She was resuscitated
and initially kept alive with respiratory
assistance and hypertransfusion therapy.
Cord blood smears revealed erythroblas-
tosis, poikilocytosis, and red cells with
stalk-like elongations. Band 3 and protein
4.2 were absent; spectrin, ankyrin, and
glycophorin A were significantly reduced.
Renal tubular acidosis was detected by
the age of 3 months. Nephrocalcinosis
appeared soon thereafter. After 3 years of
follow-up the child is doing reasonably well
on a regimen that includes regular blood
transfusions and daily bicarbonate supple-
ments. The long-term prognosis remains
uncertain given the potential for hemato-
logic and renal complications. (Blood. 2000;
96:1602-1604)
© 2000 by The American Society of Hematology
Introduction
Band 3, also known as the red cell anion exchanger 1, is encoded by
the EPB3 gene. Band 3 Coimbra (GTG3ATG; V488M) represents
a mutation at the beginning of the fourth transmembrane domain.1
Insertion of the fourth transmembrane domain is a prerequisite for
incorporation of transmembrane domains 1 through 32 and there-
fore band 3 Coimbra must represent a membrane insertion defect.
In addition, an N-terminally truncated band 3 isoform exists in
renal tubular intercalar A cells.
In the heterozygous state, band 3 Coimbra causes typical
hereditary spherocytosis (HS) and is associated with partial
deficiency of band 3 and of protein 4.2 (the latter is deficient as a
secondary phenomenon).1 In addition, certain mutations of the
EPB3 gene are responsible for dominant distal renal tubular
acidosis (DRTA).3-5 In these cases, the amount of erythrocyte
band 3 is normal and hematologic manifestations are absent. A
mutation causing band 3 deficient-HS and partial DRTA,6 or a
higher basal urinary pH,7 in the heterozygous state has been
observed.
Severe HS resulting from the absence of band 3 has been
observed in a natural strain of cattle8 and in 2 band 3 null mouse
strains engineered through targeted recombination.9,10 In one strain
glycophorin A was absent,10,11 and a susceptibility with respect to
thrombotic complications was noted.12 Severe HS in humans was
first reported by Ribeiro and colleagues.13 We herein provide a full
account of a case of severe HS associated with total absence of
band 3, as well as follow-up over a subsequent 3-year period.
Study design
Several cousins were found to be heterozygous for band 3 Coimbra,
including the patient’s mother who has had 3 pregnancies. In her first
pregnancy (1989), the fetus stopped moving near term, and a stillborn baby
with hydrops fetalis was delivered. We have almost no information on the
fetus, but we may reasonably surmise that it was homozygous for band 3
Coimbra. In her second pregnancy (1994), prenatal diagnosis, taking
advantage of an NlaIII site created by mutation Coimbra (not shown),
concluded that the fetus was homozygous for the mutation. This led to
medical termination of pregnancy after approval by the Coimbra Maternity
Ethical Committee. The placenta had a normal appearance, but on
histologic examination, a deficient formation of the capillaries and a
marked siderosis were observed. The male fetus had cervical edema and
no obvious malformation. Liver and spleen samples were unsuitable
for analysis.
The parents declined prenatal diagnosis in the third pregnancy
(1996). By week 34 of gestation, a pericardial effusion was recorded. At
week 36, there was significant ascites and anasarca, and the fetus
stopped moving. An emergency cesarean section was performed. The
hydropic female newborn had intense pallor, generalized edema,
prominent ascites, and massive hepatosplenomegaly (weight, 2445 g;
Apgar scores, 2, 8, and 9).
Red blood cell indices in cord blood were: red blood cells, 1.07 T/L;
hemoglobin, 52 g/L; hematocrit, 15.7%; mean corpuscular volume, 147
fL; mean corpuscular hemoglobin, 49 pg; mean corpuscular hemoglobin
concentration, 31 g/dL; and reticulocytes, 9.57%. Red blood cells
exhibited a wide variety of abnormal morphologies, some presenting
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with long spike-like elongations (Figure 1A). Blood transfusion,
intensive resuscitation, and assisted respiratory ventilation were imme-
diately initiated after birth. During 6 weeks in the neonatal intensive
care unit, the baby required continuous ventilation, drainage of the
ascitic fluid, and exchange transfusion (taking severe hyperbiliru-
binemia into account). A hypertransfusion regimen was started because
pretransfusion hemoglobin levels were rarely above 6.5 g/L. Erythro-
blasts and nucleated red blood cells with scant and irregular cytoplasm
were present. Iron chelating treatment was initiated when the serum
ferritin concentration reached 800 ng/L (8-12 hours of intravenous
infusion of desferroxiamine ([40 mg/kg] twice a week).
Hyperchloremic metabolic acidosis was detected by the age of 3
months. The infant received oral sodium bicarbonate (8 mEq/kg daily) and
subsequently also received monopotassium phosphate. Soon after the
discovery of blood acidosis, ultrasound showed the onset of nephrocalcino-
sis. Correcting the acidosis led to the normalization of calciuria. Nephrocal-
cinosis subsequently remained stable without impairment of glomerular
filtration.
Psychomotor development was slightly delayed, but there appeared to
be no increased susceptibility to infection, no neurologic abnormality, no
hearing impairment, and no thrombotic tendency. At the age of 3, the child
was doing reasonably well.
Red cells were obtained from umbilical cord and peripheral blood
before the first transfusion. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and Western blotting of membrane proteins and DNA
analysis were carried out as described before,1 with minor modifications.
Characterizations of the renal acidosis were based on standard
methodologies.14-16
Results and discussion
Polymerase chain reaction amplification of DNA from the child’s
white blood cells followed by NlaIII digestion demonstrated
homozygosity for mutation Coimbra. Band 3 and protein 4.2 were
absent. Spectrin a and b chains and ankyrin were reduced (by
about 43% and 57%, respectively) in comparison to protein 4.1,
which was taken as a reference (Figure 1B-D). Band 6 was strongly
diminished (Figure 1B), and glycophorin A was markedly de-
creased (Figure 1E). These features matched those described in 1
band 3 null mouse strain with a number of small differences.10,11
The urine anion gap was positive, and the value of plasma K1
was normal to decreased. The lowest urine pH after furosemide
administration was 6.6. The urine/blood PCO2 gradient was less
than 20 mm Hg after NaHCO3 loading, the fractional excretion of
HCO32 at normal plasma HCO32 concentration was 4%, and there
was a high Ca11 urinary excretion (urinary Ca11/creatinine ratio
1.2 mmol/mmol). These tests indicated a distal acidification defect
(Table 1).
The child would probably have died had not an extensive
knowledge of the family history and of the underlying mutation led
to preparation for intensive care. The prognosis is uncertain,
however. The transfusion demand will remain the same, necessitat-
ing the control of iron overload. Bone marrow transplantation with
a compatible donor would represent the most satisfactory solution.
In the meantime, a partial or total splenectomy is being considered
to reduce transfusion requirements. DRTA has been corrected with
Table 1. Differential features of renal proximal or distal tubular acidosis and
the patient’s values
Normal Patient Distal RTA Proximal RTA
During metabolic acidosis
(spontaneous)
Plasma HCO32 (mEq/L) 18-22* 15 Low Low
Plasma K1 (mEq/L) 3.5-4.5* 3.5 Normal/low Normal/low
Urine pH , 5, 5† 7.3 . 5.5 , 5.5
Urine anion gap (mEq/L) 231 6 23.5† 1 64 Positive Negative
Ca21/creat (u)
(mmol/mmol) , 0.7* 1.2 High Normal
Furosemide test




FEHCO32 (%) , 3* 4 , 5 . 10-15
U-BPCO2 (mm Hg) . 20† 15.8 , 20 . 20
Presence of
nephrocalcinosis or
lithiasis Present Common Rare
Urine anion gap, (Na1 1 K1 2 Cl2); Ca21/creat (u), urine calcium to creatinine
ratio (mmol/mmol); FEHCO32, fractional excretion of bicarbonate; U-BPCO2, urine to
blood PCO2 gradient.
When a urine sample from a patient with hyperchloremic metabolic acidosis has
a positive anion gap (Na1 1 K1 2 Cl2), a defect in distal urinary acidification is
suspected. If the value of plasma K1 is normal or decreased, the demonstration of the
inability to lower urine pH below 5.5, either after NH4Cl loading or after furosemide
administration, establishes the diagnosis of distal acidosis. The diagnosis is further
supported by a low urine/blood PCO2 gradient (, 20 mm Hg) after NaHCO3 loading. A
fractional excretion of HCO32 at normal plasma HCO32 concentration exceeding 5% of
the filtered load indicates the presence of a proximal defect in HCO32 reabsortion. To
complete the diagnostic work-up, we searched for a rise in Ca21 urinary excretion
(urinary Ca21/creatinine ratio . 0.7 mmol/mmol) and nephrocalcinosis by ultrasound.
These features are commonly found in association with distal acidosis.
*Data from Rodriguez-Soriano and Vallo.15
†Data from Dalton and Haycock.14
‡Data from Rodriguez-Soriano and Vallo.16
Figure 1. Peripheral blood smear, red cell membrane proteins, and glycophor-
ins before transfusion. (A) Red blood cells with bizarre shapes, spherocytes, and
erythroblasts with cytoplasmic elongations. (B) Coomassie blue staining. (C) West-
ern blotting of band 3 using a monoclonal antibody (Sigma, St Louis, MO). (D)
Western blotting of protein 4.2 using our own polyclonal antibody. (E) Silver staining
of glycophorins; a: control; b: patient (venous blood prior to transfusion). (B) In the
patient, band 3 and protein 4.2 were missing (denoted by 4); Spectrin a and b
chains, ankyrin were strongly reduced, as was band 6 (*). Unlike the membrane of
mice with targeted inactivation of the band 3 gene,9,10 the patient’s membrane
retained negligible amounts (4%) of hemoglobin (versus 1% in controls); residual
hemoglobin would not significantly alter the quantification of membrane proteins. The
amounts of protein 4.1 and actin were found to be rather similar to those of controls.
(C) Band 3 was present and accompanied by known proteolytic fragments (60, 41,
and 22 kd) in the control. In the patient, band 3 was totally missing (4). (D) Protein
4.2 was totally missing as well (4). (E) There was a strong reduction of the GPA dimer
(**) and a less pronounced decrease of the GPA monomer (*). The heterodimer
GPA/GPB was nearly undetectable (4). No obvious differences were recorded as for
the other glycophorins.
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oral HCO32 supplementation, but nephrocalcinosis will persist and
may cause renal failure.
A similar case of HS with missing band 3 has been identified.17 No
DRTA occurred in this instance because the frameshift mutation only
caused deletion of exon 2 and spared the renal isoform of band 3. This
work shows that intensive treatment may keep a patient with total band 3
deficiency alive. Nevertheless, potential hematologic and renal compli-
cations can be quite severe. Thus, medical termination of pregnancy, as
was done with the previous gestation, remains an alternative.
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